These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3471361)

  • 1. Mechanisms of deceleration by methylated cyclodextrins in the dehydration of prostaglandin E2 and the isomerization of prostaglandin A2 in aqueous solution.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5093-101. PubMed ID: 3471361
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative determination of some prostaglandin derivatives of the sub-groups E2, A2 and B2 by high-performance liquid chromatography.
    Amin M
    J Chromatogr; 1987 Sep; 404(2):385-90. PubMed ID: 3478343
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleophilic addition of bisulfite ion to prostaglandins E2 and A2: implication in aqueous stability.
    Cho MJ; Krueger WC; Oesterling TO
    J Pharm Sci; 1977 Feb; 66(2):149-54. PubMed ID: 14242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complexation chemistry of cycloamyloses: equilibrium constants by novel spectrophotometric methods.
    Gelb RI; Schwartz LM; Cardelino B; Laufer DA
    Anal Biochem; 1980 Apr; 103(2):362-8. PubMed ID: 7386867
    [No Abstract]   [Full Text] [Related]  

  • 6. Inclusion complexes of cyclodextrins with organic drug molecules.
    Uekama K
    Jpn J Antibiot; 1979 Dec; 32 Suppl():S103-11. PubMed ID: 398896
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase solubility analysis and PMR study of complexing behavior of dinoprostone with beta-cyclodextrin in water.
    Frank SG; Cho MJ
    J Pharm Sci; 1978 Dec; 67(12):1665-8. PubMed ID: 722476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the occurrence of three-center hydrogen bonds in cyclodextrins in crystalline form and in aqueous solution: comparison of neutron diffraction and molecular dynamics results.
    Koehler JE; Saenger W; van Gunsteren WF
    J Biomol Struct Dyn; 1988 Aug; 6(1):181-98. PubMed ID: 3271518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass spectrometric determination of prostaglandin E2, F2alpha and A2 in the cortex and medulla of the rabbit kidney.
    Larsson C; Anggård E
    J Pharm Pharmacol; 1976 Apr; 28(4):326-8. PubMed ID: 6731
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential use of cyclodextrins in parenteral formulations.
    Brewster ME; Simpkins JW; Hora MS; Stern WC; Bodor N
    J Parenter Sci Technol; 1989; 43(5):231-40. PubMed ID: 2681643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative determination of prostaglandins A1 and B1 in alprostadil (PGE1) by high-performance liquid chromatography.
    Zoutendam PH; Bowman PB; Rumph JL; Ryan TM
    J Chromatogr; 1984 Jan; 283():281-7. PubMed ID: 6538575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a non-surfactant formulation for alfaxalone through the use of chemically-modified cyclodextrins.
    Brewster ME; Estes KS; Bodor N
    J Parenter Sci Technol; 1989; 43(6):262-5. PubMed ID: 2600731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complexation of single- and double-chain surfactants by cyclomalto-oligosaccharides.
    Isnin R; Yoon HR; Vargas R; Quintela PA; Kaifer AE
    Carbohydr Res; 1989 Oct; 192():357-62. PubMed ID: 2611777
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative aqueous stabilities of dinoprostone free acid (prostaglandin E2) and its carbamoylmethyl ester.
    Stehle RG; Smith RW
    J Pharm Sci; 1976 Dec; 65(12):1844-5. PubMed ID: 25956
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereochemistry of circularly closed oligosaccharides: cyclodextrin structure and function.
    Saenger W
    Biochem Soc Trans; 1983 Apr; 11 Pt 2():136-9. PubMed ID: 6873451
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution of substituents in 2-hydroxypropyl ethers of cyclomaltoheptaose.
    Pitha J; Rao CT; Lindberg B; Seffers P
    Carbohydr Res; 1990 Apr; 200():429-35. PubMed ID: 2379216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state.
    Smulevich G; Feis A; Mazzi G; Vincieri FF
    J Pharm Sci; 1988 Jun; 77(6):523-6. PubMed ID: 3171933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of prostaglandins (PG) E2, A2 and B2 and stability studies of PGE2 in pharmaceutical preparations by ion-pair reversed phase HPLC.
    Amin M
    Pharm Acta Helv; 1989; 64(2):45-50. PubMed ID: 2717650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.